Published on 7 Oct 2023 on Simply Wall St. via Yahoo Finance
Key Insights
Given the large stake in the stock by institutions, Bicycle Therapeutics' stock price might be vulnerable to their trading decisionsThe top 14 shareholders own 51% of the companyOwnership research along with analyst forecasts data help provide a good understanding of opportunities in a stock
Every investor in Bicycle Therapeutics plc (NASDAQ:BCYC) should be aware of the most powerful shareholder groups. We can see that institutions own the lion's share in the company with 64% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.